Page last updated: 2024-09-03

imatinib mesylate and Glucose Intolerance

imatinib mesylate has been researched along with Glucose Intolerance in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belohlavkova, P; Cetkovsky, P; Faber, E; Klamova, H; Koritakova, E; Malaskova, L; Mayer, J; Prochazkova, J; Racil, Z; Rea, D; Sacha, T; Voglova, J; Wącław, J; Zackova, D; Zak, P	1

Other Studies

1 other study(ies) available for imatinib mesylate and Glucose Intolerance

Article	Year
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy. American journal of hematology, 2018, Volume: 93, Issue:10 Topics: Anthropometry; Antineoplastic Agents; Dasatinib; Glucose Intolerance; Humans; Hyperinsulinism; Imatinib Mesylate; Insulin; Insulin Resistance; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines	2018

Article

Year

Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.

American journal of hematology, 2018, Volume: 93, Issue:10

Topics: Anthropometry; Antineoplastic Agents; Dasatinib; Glucose Intolerance; Humans; Hyperinsulinism; Imatinib Mesylate; Insulin; Insulin Resistance; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines

2018